Global Tuberculosis (TB) Diagnostics Market Research Report 2022
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Culture-Based Diagnostics
1.2.3 Sputum Smear Microscopy
1.2.4 Rapid Molecular Diagnostics
1.2.5 Others
1.3 Market by Application
1.3.1 Global Tuberculosis (TB) Diagnostics Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Diagnostic Laboratories
1.3.3 Hospitals
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis (TB) Diagnostics Market Perspective (2017-2028)
2.2 Tuberculosis (TB) Diagnostics Growth Trends by Region
2.2.1 Tuberculosis (TB) Diagnostics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Tuberculosis (TB) Diagnostics Historic Market Size by Region (2017-2022)
2.2.3 Tuberculosis (TB) Diagnostics Forecasted Market Size by Region (2023-2028)
2.3 Tuberculosis (TB) Diagnostics Market Dynamics
2.3.1 Tuberculosis (TB) Diagnostics Industry Trends
2.3.2 Tuberculosis (TB) Diagnostics Market Drivers
2.3.3 Tuberculosis (TB) Diagnostics Market Challenges
2.3.4 Tuberculosis (TB) Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Tuberculosis (TB) Diagnostics Players by Revenue
3.1.1 Global Top Tuberculosis (TB) Diagnostics Players by Revenue (2017-2022)
3.1.2 Global Tuberculosis (TB) Diagnostics Revenue Market Share by Players (2017-2022)
3.2 Global Tuberculosis (TB) Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Tuberculosis (TB) Diagnostics Revenue
3.4 Global Tuberculosis (TB) Diagnostics Market Concentration Ratio
3.4.1 Global Tuberculosis (TB) Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tuberculosis (TB) Diagnostics Revenue in 2021
3.5 Tuberculosis (TB) Diagnostics Key Players Head office and Area Served
3.6 Key Players Tuberculosis (TB) Diagnostics Product Solution and Service
3.7 Date of Enter into Tuberculosis (TB) Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Tuberculosis (TB) Diagnostics Breakdown Data by Type
4.1 Global Tuberculosis (TB) Diagnostics Historic Market Size by Type (2017-2022)
4.2 Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Type (2023-2028)
5 Tuberculosis (TB) Diagnostics Breakdown Data by Application
5.1 Global Tuberculosis (TB) Diagnostics Historic Market Size by Application (2017-2022)
5.2 Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Tuberculosis (TB) Diagnostics Market Size (2017-2028)
6.2 North America Tuberculosis (TB) Diagnostics Market Size by Country (2017-2022)
6.3 North America Tuberculosis (TB) Diagnostics Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Tuberculosis (TB) Diagnostics Market Size (2017-2028)
7.2 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2017-2022)
7.3 Europe Tuberculosis (TB) Diagnostics Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size (2017-2028)
8.2 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Country (2017-2022)
8.3 Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Tuberculosis (TB) Diagnostics Market Size (2017-2028)
9.2 Latin America Tuberculosis (TB) Diagnostics Market Size by Country (2017-2022)
9.3 Latin America Tuberculosis (TB) Diagnostics Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size (2017-2028)
10.2 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2017-2022)
10.3 Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Danaher
11.1.1 Danaher Company Detail
11.1.2 Danaher Business Overview
11.1.3 Danaher Tuberculosis (TB) Diagnostics Introduction
11.1.4 Danaher Revenue in Tuberculosis (TB) Diagnostics Business (2017-2022)
11.1.5 Danaher Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Tuberculosis (TB) Diagnostics Introduction
11.2.4 Roche Revenue in Tuberculosis (TB) Diagnostics Business (2017-2022)
11.2.5 Roche Recent Development
11.3 Thermo Fisher Scientific
11.3.1 Thermo Fisher Scientific Company Detail
11.3.2 Thermo Fisher Scientific Business Overview
11.3.3 Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Introduction
11.3.4 Thermo Fisher Scientific Revenue in Tuberculosis (TB) Diagnostics Business (2017-2022)
11.3.5 Thermo Fisher Scientific Recent Development
11.4 BD
11.4.1 BD Company Detail
11.4.2 BD Business Overview
11.4.3 BD Tuberculosis (TB) Diagnostics Introduction
11.4.4 BD Revenue in Tuberculosis (TB) Diagnostics Business (2017-2022)
11.4.5 BD Recent Development
11.5 Abbott
11.5.1 Abbott Company Detail
11.5.2 Abbott Business Overview
11.5.3 Abbott Tuberculosis (TB) Diagnostics Introduction
11.5.4 Abbott Revenue in Tuberculosis (TB) Diagnostics Business (2017-2022)
11.5.5 Abbott Recent Development
11.6 Hologic
11.6.1 Hologic Company Detail
11.6.2 Hologic Business Overview
11.6.3 Hologic Tuberculosis (TB) Diagnostics Introduction
11.6.4 Hologic Revenue in Tuberculosis (TB) Diagnostics Business (2017-2022)
11.6.5 Hologic Recent Development
11.7 Qiagen
11.7.1 Qiagen Company Detail
11.7.2 Qiagen Business Overview
11.7.3 Qiagen Tuberculosis (TB) Diagnostics Introduction
11.7.4 Qiagen Revenue in Tuberculosis (TB) Diagnostics Business (2017-2022)
11.7.5 Qiagen Recent Development
11.8 BioMerieux
11.8.1 BioMerieux Company Detail
11.8.2 BioMerieux Business Overview
11.8.3 BioMerieux Tuberculosis (TB) Diagnostics Introduction
11.8.4 BioMerieux Revenue in Tuberculosis (TB) Diagnostics Business (2017-2022)
11.8.5 BioMerieux Recent Development
11.9 Hain Lifescience
11.9.1 Hain Lifescience Company Detail
11.9.2 Hain Lifescience Business Overview
11.9.3 Hain Lifescience Tuberculosis (TB) Diagnostics Introduction
11.9.4 Hain Lifescience Revenue in Tuberculosis (TB) Diagnostics Business (2017-2022)
11.9.5 Hain Lifescience Recent Development
11.10 Oxford Immunotec
11.10.1 Oxford Immunotec Company Detail
11.10.2 Oxford Immunotec Business Overview
11.10.3 Oxford Immunotec Tuberculosis (TB) Diagnostics Introduction
11.10.4 Oxford Immunotec Revenue in Tuberculosis (TB) Diagnostics Business (2017-2022)
11.10.5 Oxford Immunotec Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Tuberculosis (TB) Diagnostics Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Culture-Based Diagnostics
Table 3. Key Players of Sputum Smear Microscopy
Table 4. Key Players of Rapid Molecular Diagnostics
Table 5. Key Players of Others
Table 6. Global Tuberculosis (TB) Diagnostics Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Tuberculosis (TB) Diagnostics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Tuberculosis (TB) Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Tuberculosis (TB) Diagnostics Market Share by Region (2017-2022)
Table 10. Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Tuberculosis (TB) Diagnostics Market Share by Region (2023-2028)
Table 12. Tuberculosis (TB) Diagnostics Market Trends
Table 13. Tuberculosis (TB) Diagnostics Market Drivers
Table 14. Tuberculosis (TB) Diagnostics Market Challenges
Table 15. Tuberculosis (TB) Diagnostics Market Restraints
Table 16. Global Tuberculosis (TB) Diagnostics Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Tuberculosis (TB) Diagnostics Market Share by Players (2017-2022)
Table 18. Global Top Tuberculosis (TB) Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis (TB) Diagnostics as of 2021)
Table 19. Ranking of Global Top Tuberculosis (TB) Diagnostics Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Tuberculosis (TB) Diagnostics Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Tuberculosis (TB) Diagnostics Product Solution and Service
Table 23. Date of Enter into Tuberculosis (TB) Diagnostics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Tuberculosis (TB) Diagnostics Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2017-2022)
Table 27. Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Type (2023-2028)
Table 29. Global Tuberculosis (TB) Diagnostics Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2017-2022)
Table 31. Global Tuberculosis (TB) Diagnostics Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Tuberculosis (TB) Diagnostics Revenue Market Share by Application (2023-2028)
Table 33. North America Tuberculosis (TB) Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Tuberculosis (TB) Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Tuberculosis (TB) Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Tuberculosis (TB) Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Tuberculosis (TB) Diagnostics Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Tuberculosis (TB) Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Tuberculosis (TB) Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size by Country (2023-2028) & (US$ Million)
Table 43. Danaher Company Detail
Table 44. Danaher Business Overview
Table 45. Danaher Tuberculosis (TB) Diagnostics Product
Table 46. Danaher Revenue in Tuberculosis (TB) Diagnostics Business (2017-2022) & (US$ Million)
Table 47. Danaher Recent Development
Table 48. Roche Company Detail
Table 49. Roche Business Overview
Table 50. Roche Tuberculosis (TB) Diagnostics Product
Table 51. Roche Revenue in Tuberculosis (TB) Diagnostics Business (2017-2022) & (US$ Million)
Table 52. Roche Recent Development
Table 53. Thermo Fisher Scientific Company Detail
Table 54. Thermo Fisher Scientific Business Overview
Table 55. Thermo Fisher Scientific Tuberculosis (TB) Diagnostics Product
Table 56. Thermo Fisher Scientific Revenue in Tuberculosis (TB) Diagnostics Business (2017-2022) & (US$ Million)
Table 57. Thermo Fisher Scientific Recent Development
Table 58. BD Company Detail
Table 59. BD Business Overview
Table 60. BD Tuberculosis (TB) Diagnostics Product
Table 61. BD Revenue in Tuberculosis (TB) Diagnostics Business (2017-2022) & (US$ Million)
Table 62. BD Recent Development
Table 63. Abbott Company Detail
Table 64. Abbott Business Overview
Table 65. Abbott Tuberculosis (TB) Diagnostics Product
Table 66. Abbott Revenue in Tuberculosis (TB) Diagnostics Business (2017-2022) & (US$ Million)
Table 67. Abbott Recent Development
Table 68. Hologic Company Detail
Table 69. Hologic Business Overview
Table 70. Hologic Tuberculosis (TB) Diagnostics Product
Table 71. Hologic Revenue in Tuberculosis (TB) Diagnostics Business (2017-2022) & (US$ Million)
Table 72. Hologic Recent Development
Table 73. Qiagen Company Detail
Table 74. Qiagen Business Overview
Table 75. Qiagen Tuberculosis (TB) Diagnostics Product
Table 76. Qiagen Revenue in Tuberculosis (TB) Diagnostics Business (2017-2022) & (US$ Million)
Table 77. Qiagen Recent Development
Table 78. BioMerieux Company Detail
Table 79. BioMerieux Business Overview
Table 80. BioMerieux Tuberculosis (TB) Diagnostics Product
Table 81. BioMerieux Revenue in Tuberculosis (TB) Diagnostics Business (2017-2022) & (US$ Million)
Table 82. BioMerieux Recent Development
Table 83. Hain Lifescience Company Detail
Table 84. Hain Lifescience Business Overview
Table 85. Hain Lifescience Tuberculosis (TB) Diagnostics Product
Table 86. Hain Lifescience Revenue in Tuberculosis (TB) Diagnostics Business (2017-2022) & (US$ Million)
Table 87. Hain Lifescience Recent Development
Table 88. Oxford Immunotec Company Detail
Table 89. Oxford Immunotec Business Overview
Table 90. Oxford Immunotec Tuberculosis (TB) Diagnostics Product
Table 91. Oxford Immunotec Revenue in Tuberculosis (TB) Diagnostics Business (2017-2022) & (US$ Million)
Table 92. Oxford Immunotec Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Tuberculosis (TB) Diagnostics Market Share by Type: 2021 VS 2028
Figure 2. Culture-Based Diagnostics Features
Figure 3. Sputum Smear Microscopy Features
Figure 4. Rapid Molecular Diagnostics Features
Figure 5. Others Features
Figure 6. Global Tuberculosis (TB) Diagnostics Market Share by Application in 2021 & 2028
Figure 7. Diagnostic Laboratories Case Studies
Figure 8. Hospitals Case Studies
Figure 9. Tuberculosis (TB) Diagnostics Report Years Considered
Figure 10. Global Tuberculosis (TB) Diagnostics Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Tuberculosis (TB) Diagnostics Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Tuberculosis (TB) Diagnostics Market Share by Region: 2021 VS 2028
Figure 13. Global Tuberculosis (TB) Diagnostics Market Share by Players in 2021
Figure 14. Global Top Tuberculosis (TB) Diagnostics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tuberculosis (TB) Diagnostics as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Tuberculosis (TB) Diagnostics Revenue in 2021
Figure 16. North America Tuberculosis (TB) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Tuberculosis (TB) Diagnostics Market Share by Country (2017-2028)
Figure 18. United States Tuberculosis (TB) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Tuberculosis (TB) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Tuberculosis (TB) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Tuberculosis (TB) Diagnostics Market Share by Country (2017-2028)
Figure 22. Germany Tuberculosis (TB) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Tuberculosis (TB) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Tuberculosis (TB) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Tuberculosis (TB) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Tuberculosis (TB) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Tuberculosis (TB) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Tuberculosis (TB) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Tuberculosis (TB) Diagnostics Market Share by Region (2017-2028)
Figure 30. China Tuberculosis (TB) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Tuberculosis (TB) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Tuberculosis (TB) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Tuberculosis (TB) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Tuberculosis (TB) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Tuberculosis (TB) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Tuberculosis (TB) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Tuberculosis (TB) Diagnostics Market Share by Country (2017-2028)
Figure 38. Mexico Tuberculosis (TB) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Tuberculosis (TB) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Tuberculosis (TB) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Tuberculosis (TB) Diagnostics Market Share by Country (2017-2028)
Figure 42. Turkey Tuberculosis (TB) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Tuberculosis (TB) Diagnostics Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Danaher Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2017-2022)
Figure 45. Roche Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2017-2022)
Figure 46. Thermo Fisher Scientific Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2017-2022)
Figure 47. BD Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2017-2022)
Figure 48. Abbott Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2017-2022)
Figure 49. Hologic Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2017-2022)
Figure 50. Qiagen Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2017-2022)
Figure 51. BioMerieux Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2017-2022)
Figure 52. Hain Lifescience Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2017-2022)
Figure 53. Oxford Immunotec Revenue Growth Rate in Tuberculosis (TB) Diagnostics Business (2017-2022)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed